Don't hold. Don't understand the stock. Doesn't understand the...

Don't hold. Don't understand the stock. Doesn't understand the biotech sector and the colossal rewards that await holders if everything lines, up, (and these are lining up IMO).

Doesn't appreciate the ground breaking properties of MSB's stem cells.

Doesn't understand the relevance of the CHF, indeed any trials.

Let alone the current engagement with the FDA, or the crucial relevance of our treatment for ARDS in the Covid19 era.

Doesn't appreciate why the risk with future possible and more deadly Covid19 mutations is that the vaccines may not be able to be modified/developed before they take off.

That's a real risk that the FDA and EUA must be aware of. It makes just this ONE application of remestemcell-L hugely valuable.

Indeed it must be why Silviu Itescu said the FDA was 'highly motivated' to move ahead. It means nothing, nada to you. All glossed over in the ceaseless dismissal of this emerging behemoth.

Nothing, no relevant information sticks.
Discussion is on this relentless agitation cycle of cheap throwaway lines and dismissive untrue claims.

Why exactly are you here, sorepocket?

It seems obvious to some. But I'd like to hear you justify yourself and the low quality of engagement you make it your business to do. Always the cliches.